The FDA’s Rigged Drug Committees

Among the Republican priorities in 2017 should be dismantling a culture of bureaucratic control at the Food and Drug Administration that poisons innovation and costs lives. Here's an idea: Update part of the approval process that was patient zero for distorting data on a drug for Duchenne muscular dystrophy.